Australian Stocks Trading Below Fair Value Based On Cash Flows

Global markets are wrestling with mixed inflation signals, shifting rate paths, and swings in energy prices, which leaves many investors unsure where to focus. One way to cut through the noise is to look at companies where current prices stand below an estimate of fair value based on cash flows. That is exactly what the Undervalued Stocks Based On Cash Flows screener targets, highlighting businesses that SWS DCF valuation flags as potentially mispriced. In this article, you will see 3 stocks from the screener that may appeal to value-oriented investors looking for ideas built on cash flow fundamentals rather than hype.

Mesoblast (ASX:MSB)

Overview: Mesoblast develops regenerative medicine therapies using mesenchymal lineage cells to treat severe inflammatory, cardiovascular, and chronic pain conditions, such as graft versus host disease, inflammatory bowel disease, chronic heart failure, and chronic low back pain. The company partners with larger pharmaceutical groups to progress these cell therapies through late stage trials and into commercial use across key global healthcare markets.

Operations: Mesoblast currently generates about US$65.4 million in revenue from the development of its cell technology platform for commercialization.

Market Cap: A$2.8b

Mesoblast stands out in the screener because its share price sits below an estimate of fair value based on future cash flows, yet the company is already generating revenue from its cell therapy platform while working on several late stage programs in high need areas like chronic low back pain and heart failure. Analysts expect very strong revenue and earnings growth over the coming years, although the company is still reporting losses and relies heavily on external funding, which raises financing risk if trials or approvals are delayed. For investors comfortable with biotech risk, Mesoblast provides exposure to a maturing cell therapy platform. The key considerations are how the pipeline progresses, how the reimbursement environment develops, and how the funding profile changes over time.

Mesoblast’s late stage pipeline and current revenue stream can make the stock look like an overlooked cash flow story in the making, but the real twist may sit inside the analyst forecasts for Mesoblast

Lynas Rare Earths (ASX:LYC)

Overview: Lynas Rare Earths is an integrated rare earths miner and processor, extracting ore from its Mt Weld mine in Western Australia and refining it into high value materials at plants in Kalgoorlie and Malaysia that feed into electric vehicles, wind turbines, electronics, and defense supply chains.

Operations: Lynas Rare Earths generates about A$715.9 million in revenue from its rare earth operations business.

Market Cap: A$15.0b

Lynas Rare Earths sits at the center of the push for non Chinese rare earth supply as governments look to secure materials for electrification and defense. The stock is flagged by the cash flow screener as trading below an estimate of fair value. Analysts are building in strong revenue and earnings growth, helped by downstream steps like the JS Link magnet partnership in Malaysia. This is balanced by regulatory scrutiny, concentrated products, and reliance on higher risk borrowing. For investors, the tension between high growth expectations, fair value signals, and policy risk is what makes Lynas so interesting to study closely before deciding how it fits in a portfolio focused on cash flow potential.

Lynas Rare Earths sits at the intersection of cash flow potential, policy support, and supply chain tension, and the real story sits inside the analysis report for Lynas Rare Earths

WiseTech Global (ASX:WTC)

Overview: WiseTech Global develops and sells cloud software that helps logistics companies manage the end to end movement and storage of goods and data, from freight forwarding and customs clearance to warehousing and transport, across the Americas, Asia Pacific, Europe, the Middle East, and Africa.

Operations: WiseTech Global generates revenue from logistics software solutions across the Americas (US$450.7 million), Asia Pacific (US$254.8 million), and Europe, the Middle East and Africa (US$364.2 million).

Market Cap: A$10.7b

WiseTech Global attracts investor interest because it operates at the center of supply chain digitization, with unified, AI driven SaaS products and the E2open acquisition broadening its reach across the full global freight chain. Some analysts highlight earnings and revenue growth potential, supported by recurring software revenue and new products like Container Transport Optimization that may open additional income streams. However, the picture is complex. Organic growth has slowed, margins have recently compressed, and the shift to transaction based pricing plus higher leverage from a A$3b debt facility introduce additional risk if integrations or product rollouts do not meet expectations. For investors weighing faster expansion against execution and balance sheet pressure, there are multiple factors to consider.

WiseTech Global’s accelerating push across the freight chain, powered by recurring software revenue and new products, could be masking one crucial pressure point that many investors are missing, and the full picture sits inside the analysis report for WiseTech Global

The three stocks in this article are just a starting point, and the full Undervalued Stocks Based On Cash Flows screener surfaces 33 more companies where cash flow potential and discounted valuations combine into equally compelling stories. Use Simply Wall St to identify and analyze the specific cash flow catalysts, balance sheet traits, and valuation narratives that matter most, so you can focus on the ideas that best fit your highest conviction plays.

Take Control of Your Investment Journey

If Mesoblast or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

Some of the most interesting breakout stories start quietly, while momentum is building and prices have not yet taken off. Catch fresh ideas that are under the radar for now and consider them before they attract wider attention.

• Spot steady compounders by scanning list of solid balance sheet and fundamentals (19 results) that can keep moving while others stall, so you are not chasing strength after the crowd piles in.
• Ride structural growth trends early by filtering 55 AI infrastructure stocks, where demand for computing backbone is building and potential leaders are still dropping under most investors’ screens.
• Position ahead of a potential resource upswing by zeroing in on 33 elite gold producer stocks before sentiment shifts and quality producers experience renewed momentum.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com